April 29, 2009 –
|
RELATED TICKERS: MYGN
Myriad Genetics, Inc. Board of Directors has authorized management to proceed with preparations to spin off its research and drug development businesses from its molecular diagnostics business to form two well-capitalized, highly-focused, independent public companies. [more]
April 20, 2009 –
|
RELATED TICKERS: CPD
, MYL
, TEVA
spoke with the investor relations representative for Caraco Pharma (CPD) earlier this week and received some clarity on the expected timeline for resolving the major overhang on the stock price related to the FDA warning letter over Form 483 concerns by the agency stemming from quality control issues raised during an inspection of manufacturing facilities last year.
Caraco has responded in full to the warning letter and the FDA will evaluate the corrective actions taken by the Company at its next scheduled inspection, which is expected to occur some time in May. Caraco believes it is compliant with the FDA's cGMP regulations related to manufacturing and quality control and the issue remains the top focus at the Company, reflected by investments in personnel and facility upgrades. The Company expects the FDA inspection in May to be the final step in resolving the warning letter issues as the agency will evaluate Caraco's upgrades in manufacturing and quality control at the Detroit facility to determine if these actions satisfy the agency's Form 483 concerns. [more]
May 12, 2008 –
|
RELATED TICKERS: KMT
, CMP
, TRMB
People are starving, fed is shelling out subsidaries to farmers and what better way to spend them but to update the technology in their fields. Irrigation will be a boom, im very bullish on fertilizers but i am waiting on a pullback on many of the potash stocks before I dive back in. [more]